Also trades as: KYNB (NASDAQ) · $vol 0M
0IL8.L LSE
Kyntra Bio, Inc.
1W: -6.9%
1M: -24.0%
3M: -17.1%
YTD: -20.6%
1Y: -32.4%
3Y: -89.7%
$6.36
-0.51 (-7.42%)
Weekly Expected Move ±5.9%
$6
$6
$6
$7
$7
Overview
News
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$5M
+96.5% ▲
Capital Expenditures
$38K
+85.7% ▲
5Y CAGR: -60.6%
Free Cash Flow
-$5M
+96.5% ▲
Dividends Paid
$4M
-77.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$54M
-371.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$290M | -$294M | -$284M | -$48M | $183M |
| Depreciation & Amort. | $15M | $11M | $10M | $3M | $748K |
| Stock-Based Comp. | $71M | $66M | $51M | $25M | $7M |
| Change in Working Capital | $60M | $70M | -$120M | -$117M | $0 |
| Other Non-Cash Items | $62M | $1M | $28M | -$868K | -$196M |
| Operating Cash Flow | -$82M | -$146M | -$315M | -$138M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$5M | -$4M | -$3M | -$266K | -$38K |
| Acquisitions (Net) | $0 | $0 | $656K | $1M | $0 |
| Investment Purchases | -$484M | -$164M | -$252M | -$9M | -$61M |
| Investment Sales | $87M | $292M | $407M | $134M | $0 |
| Other Investing | -$25M | -$35M | $0 | $0 | $97M |
| Investing Cash Flow | -$427M | $89M | $154M | $126M | $35M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$6M | -$538K | $74M | -$40K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$2M | -$4M |
| Other Financing | -$7M | $43M | $748K | $2M | -$82M |
| Financing Cash Flow | -$563K | $47M | $123M | -$255K | -$86M |
| Net Change in Cash | -$507M | -$16M | -$42M | -$12M | -$54M |
| Cash End of Period | $171M | $156M | $114M | $102M | $48M |
| Free Cash Flow | -$112M | -$185M | -$318M | -$138M | -$5M |